Abstract:Background: Lung cancer (LC) is the leading cause of cancer related deaths, and several countries are implementing screening programs. Risk models have been introduced to refine the LC screening criteria, but the use of real-world data for this task demands a robust data infrastructure and quality. In this retrospective cohort study, we aim to address the different relevant risk factors in terms of data sources, descriptive statistics, completeness and quality. Methods: Data on comorbidity, prescription medication, smoking history, consultations, symptoms, familial predispositions, exposures, laboratory data among others were collected for all patients examined on a risk of LC over a 10-year period in the Region of Southern Denmark. Data were delivered from the regional data warehouse as well as the Danish Lung Cancer Registry. Associations between LC and non-LC groups were examined through Chi-squared test (categorical variables) and Wilcoxon signed-rank test (continuous variables that were non-parametric). These associations were investigated on both the original datasets and the subset of patients with complete data. Results: The number of examined individuals increased over the study period and more patients were diagnosed with LC in stage I-II, from 18% in 2009 to 31% in 2018. LC patients were more likely to be older, smoker, with a registered prescription of the included medication. They also exhibited differences in laboratory analysis indicating inflammation and hyponatremia. Weight loss, fatigue and pain were more prevalent in the LC group, while hemoptysis and fever were more common among the non-LC patients. Advanced-stage LC patients experienced a higher rate of symptoms compared to those in the low stages. Within the sub-cohort with complete dataset results, most observed trends persisted, although data on comorbidities were susceptibility to change. Conclusions: This study provides key insights into LC risk assessment using a robust dataset of patients examined for suspected LC. A consistent positive trend in early-stage LC diagnosis was observed throughout the study period. LC patients exhibited distinct smoking behaviors, medication patterns, variations in lab results, and specific symptoms. These discoveries have the potential to enhance discrimination in machine learning-based prediction models, particularly those capable of handling complex distributions. Serving as a detailed account of real-world data collection and processing, the study establishes a foundation for future development of prediction models aimed at facilitating the early referral of LC patients.

Intensity of care, expenditure, place and cause of death people with lung cancer in the year before their death: A French population based study

Differences in Health Care Expenditures by Cancer Patients During Their Last Year of Life: A Registry-Based Study

Multicentre analysis of intensity of care at the end-of-life in patients with advanced cancer, combining health administrative data with hospital records: variations in practice call for routine quality evaluation

Risk factors for early mortality of lung cancer patients in France: A nationwide analysis

Access to primary care and mortality in excess for patients with cancer in France: Results from 21 French Cancer Registries

Potentially burdensome care at the end-of-life for cancer decedents: a retrospective population-wide study

Racial and Ethnic Disparities in Intensity of Care at the End of Life for Patients With Lung Cancer: A 13-Year Population-Based Study

Why is end‐of‐life inpatient cost high among cancer patients? A prospective cohort study

Health care use and costs at the end of life: a comparison of elderly Australian decedents with and without a cancer history

Indicators for early assessment of palliative care in lung cancer patients: a population study using linked health data

COVID-19 among lung cancer patients: data from a real-life prospective French multicentric study

Differences in Healthcare and Palliative Care Utilization at the End of Life: a Comparison Study Between Lung Cancer, COPD, and IPF

Inpatient deaths by medical service: characteristics in a comprehensive cancer centre

Palliative care interventions and end-of-life care for patients with metastatic breast cancer: a multicentre analysis

The use of in-hospital medical care for patients with metastasized colon, bronchus, or lung cancer

Primary care usage at the end of life: a retrospective cohort study of cancer patients using linked primary and hospital care data

Healthcare use and costs in the last six months of life by level of care and cause of death

A collection of multiregistry data on patients at high risk of lung cancer-a Danish retrospective cohort study of nearly 40,000 patients

Trends in End-of-Life ICU Use Among Older Adults With Advanced Lung Cancer

Continuity of Care and Intensive Care Unit Use at the End of Life

Estimating the cost of caring for people with cancer at the end of life: A modelling study